Reuters Health Report

Click to View in Browser 05/23/2014 Studies still looking for link between cell phones and brain tumors NEW YORK (Reuters Health) - The heaviest users of cell phones may be at higher than average risk of being diagnosed with a brain tumor, according to a recent French study. EU agency recommends against Novartis heart failure drug ZURICH (Reuters) - EU health regulators have recommended against approving Novartis's experimental heart failure drug for the second time this year due to insufficient evidence it improves symptoms, the Swiss drugmaker said in a statement on Friday. Athlete anxiety no excuse to skip heart test: study NEW YORK (Reuters Health) - After finding that student-athletes felt no more distress about heart screening with electrocardiograms, or ECGs, than they did with physical exams, a new study concludes that anxiety should not be considered a reason to avoid giving the test. Mexico reports deadly pig virus in 17 states out of 19 tested PARIS (Reuters) - Mexico reported outbreaks of a deadly pig virus in 17 states out of 19 tested, the World Animal Health Organization (OIE) said on Thursday. U.S. investigates multi-state E.coli outbreak; no deaths reported (Reuters) - U.S. health officials are investigating a multi-state E.coli outbreak linked to raw clover sprouts that have sickened as many as 10 people, half of whom required hospitalization, the Food and Drug Administration said on Thursday. No deaths have been reported. Pfizer psoriasis drug succeeds in late-stage trial (Reuters) - Pfizer Inc said its experimental psoriasis drug was effective in treating the condition in a late-stage trial. PTC shares soar on EU backing for muscular dystrophy drug LONDON (Reuters) - Shares in U.S. biotech company PTC Therapeutics more than doubled in premarket dealings on Friday after European regulators recommended a conditional marketing authorization for Translarna, its drug for Duchenne muscular dystrophy. EU agency recommends new drugs from Roche, Biogen and PTC LONDON (Reuters) - European regulators said on Friday they had recommended approval of Roche's drug Gazyvaro, or obinutuzumab, for patients with chronic lymphocytic leukemia, boosting the Swiss group's line-up of new cancer treatments. Wastewater a source of antibiotic-resistant bacteria: study NEW YORK (Reuters Health) - Wastewater from cities and hospitals releases some antibiotic-resistant bacteria into the environment, according to a new French study. Childhood trauma may leave its mark in blood vessels NEW YORK (Reuters Health) - Young adults who were exposed to adverse experiences as children have greater signs of unhealthy blood vessel function than young people without a traumatic past, a new study finds. Related Video Extreme thunderstorms in Colorado cause flooding, hail Reef fish lose brain power as oceans acidify The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend